Results for tag: "Hyperpigmentation Drug"

The Hyperpigmentation Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Hyperpigmentation Drugs are used to treat conditions such as melasma, age spots, and post-inflammatory hyperpigmentation. These drugs are typically topical creams, lotions, or gels that contain active ingredients such as hydroquinone, tretinoin, and corticosteroids. These drugs work by inhibiting the production of melanin, the pigment that causes dark spots on the skin. The Hyperpigmentation Drug market is highly competitive, with many companies offering products that contain different active ingredients. Some of the major players in the market include Galderma, Allergan, and Johnson & Johnson. Other companies in the market include Valeant Pharmaceuticals, Merck, and Sun Pharmaceuticals. Show Less Read more